Orpheus Uranium Ltd
OTC:AGREF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Orpheus Uranium Ltd
OTC:AGREF
|
AU |
|
Oculus Inc
F:USF1
|
CA |
|
Ascopiave SpA
MIL:ASC
|
IT |
|
OSE Immunotherapeutics SA
F:6OP
|
FR |
|
G
|
Grenergy Renovables SA
XMUN:5GR
|
ES |
|
D
|
Duluth Holdings Inc
F:6DU
|
US |
|
Schindler Holding AG
SIX:SCHP
|
CH |
Intrinsic Value
Is AGREF undervalued or overvalued?
See the intrinsic value estimate for 
Orpheus Uranium Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
AGREF looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with AGREF’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Orpheus Uranium Does
Orpheus Uranium Ltd. is a mineral exploration and development company, which engages in the uranium exploration in South Australia and the Northern Territory. The company is headquartered in Adelaide, South Australia. The firm has extended tenure into Western Australia through the acquisition of the Oobagooma Uranium Project. Its projects include Pirie Basin, Frome, Radium Hill South, Marree, and Mount Douglas.
- Headquarters
- Australia AU
- IPO date
- Jan 23, 1986
Earnings Waterfall
Orpheus Uranium Ltd
The intrinsic value for Orpheus Uranium Ltd (AGREF) under the Base Case is hidden USD.
Compared with the current market price of 0.08 USD, the stock appears hidden.